The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Abstract
The complexity of eukaryotic gene regulation is slowly being resolved. What has become clear is that transcriptional regulation is a multi-step process that involves the assembly of macromolecular complexes. This review will discuss the biology of the ETS family transcription factor PU.1, with emphasis on its interactions with two members of the Interferon Regulatory Factor (IRF) family, interferon consensus sequence binding protein (ICSBP), and IRF-4. The role of these interactions in transcriptional regulation is discussed, with respect to DNA binding motifs, protein-protein interaction and phosphorylation states that modulate PU.1/IRF interactions. Furthermore, potential transcriptional mechanisms for several genes are discussed, focusing on genes involved in innate immunity. Data from these studies suggest at least four distinct paradigms for transcriptional regulation by an ETS protein in conjunction with either ICSBP or IRF-4. These paradigms may describe regulatory mechanisms common to many distinct transcription factor families. Last, recent data from several laboratories have now documented the expression of ICSBP and IRF-4 in a range of cell types. These data suggest that ICSBP and IRF-4 may serve functions within these cell types that are distinct from their previously recognized functions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Pip/NF-EM5/IRF-4 is a lymphoid-restricted transcription factor recruited to a composite element (IRF/ETS-binding site) within Ig light chain enhancers through a specific interaction with PU.1 protein.
“Pip/NF-EM5/IRF-4, a member of IRF family, is a lymphoid-restricted transcription factor that is recruited to a composite element (IRF/ETS-binding site) within Ig light chain enhancers through a specific interaction with PU.1 protein [116, 117].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [116]
Citations
Cites
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957
Lin, R., Heylbroeck, C., Pitha, P. M., & Hiscott, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2986 · Cited by 915
The Ets family of transcription factors
Wasylyk, B., Hahn, S. L., & Giovane, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb19864.x · Cited by 839
Regulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749
Holtschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 576
Osteopetrosis in mice lacking haematopoietic transcription factor PU.1
Tondravi, M. M., McKercher, S. R., Anderson, K., Erdmann, J. M., Quiroz, M. E., Maki, R. A., & Teitelbaum, S. L. (1997) · Nature · doi:10.1038/386081a0 · Cited by 537
The growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
Zhang, D.-E., Hetherington, C. J., Chen, H.-M., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.373-381.1994 · Cited by 411
Structure of IRF-1 with bound DNA reveals determinants of interferon regulation
Escalante, C. R., Yie, J., Thanos, D., & Aggarwal, A. K. (1998) · Nature · doi:10.1038/34224 · Cited by 397 · cited 2×
“Several studies suggest that this DBD forms a wHTH structure (68,69).”
BackgroundAu, W.-C., Moore, P. A., Lowther, W. J., Juang, Y., & Pitha, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11657 · Cited by 388
Driggers, P. H., Ennist, D. L., Gleason, S. L., Mak, W. H., Marks, M. S., Levi, B. Z., Flanagan, J. R., Appella, E., & Ozato, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3743 · Cited by 356
Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A., & Atchison, M. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.368 · Cited by 354
Fujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimura, Y., & Taniguchi, T. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03213.x · Cited by 347
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
Iida, S., Rao, P. H., Butler, M. P., Corradini, P., Boccadoro, M., Klein, B., CHAGANTI, R. S. K., & Dalla‐Favera, R. (1997) · Nature Genetics · doi:10.1038/ng1097-226 · Cited by 336
A new pattern for helix–turn–helix recognition revealed by the PU.l ETS–domain–DNA complex
Kodandapani, R., Pio, F., Ni, C.-Z., Piccialli, G., Klemsz, M., McKercher, S., Maki, R. A., & Ely, K. R. (1996) · Nature · doi:10.1038/380456a0 · Cited by 315
Hagemeier, C., Bannister, A. J., Cook, A., & Kouzarides, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1580 · Cited by 303
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter
Pahl, H. L., Scheibe, R. J., Zhang, D. E., Chen, H. M., Galson, D. L., Maki, R. A., & Tenen, D. G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53496-7 · Cited by 301
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation
Pongubala, J., Van Beveren, C., Nagulapalli, S., Klemsz, M., McKercher, Maki, R., & Atchison, M. (1993) · Science · doi:10.1126/science.8456286 · Cited by 271 · cited 15×
“As noted above, PU.1 can also interact with the IRF family members ICSBP and IRF-4 (6,7,17).”
BackgroundInfluentialRegulation of Type I Interferon Gene Expression by Interferon Regulatory Factor-3
Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J. B., & Pitha, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2714 · Cited by 266
Searles, R. P., Bergquam, E. P., Axthelm, M. K., & Wong, S. W. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3040-3053.1999 · Cited by 265
Sirover, M. A. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970801)66:2 · Cited by 245
Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242
John, S., Reeves, R., Lin, J., Child, R., Leiden, J. M., Thompson, C. B., & Leonard, W. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1786 · Cited by 241
Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins
Nelsen, B., Tian, G., Erman, B., Gregoire, J., Maki, R., Graves, B., & Sen, R. (1993) · Science · doi:10.1126/science.8316859 · Cited by 222
Scharton-Kersten, T., Contursi, C., Masumi, A., Sher, A., & Ozato, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1523 · Cited by 217
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis
Fenton, M. J., Vermeulen, M. W., Kim, S., Burdick, M., Strieter, R. M., & Kornfeld, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.5149-5156.1997 · Cited by 209
Self-citationBrass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 204 · cited 1×
“1 and IRF-4 DBDs, connected by a flexible linker, inhibited Ig λ light chain enhancer expression in B cells, implying in vivo binding of this element (110).”
BackgroundRel Induces Interferon Regulatory Factor 4 (IRF-4) Expression in Lymphocytes
Grumont, R. J., & Gerondakis, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1281 · Cited by 201
Lack of Interferon Consensus Sequence Binding Protein (ICSBP) Transcripts in Human Myeloid Leukemias
Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J. F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I., et al. (1998) · Blood · doi:10.1182/blood.v91.1.22 · Cited by 199
Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 196
Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196
Myeloid Development Is Selectively Disrupted in PU.1 Null Mice
Anderson, K. L., Smith, K. A., Conners, K., McKercher, S. R., Maki, R. A., & Torbett, B. E. (1998) · Blood · doi:10.1182/blood.v91.10.3702 · Cited by 193
Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588 · Cited by 192
Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.588-599.1993 · Cited by 192 · cited 2×
“For example, both ICSBP and IRF-4 function as repressors when bound to ISRE elements (53,74).”
BackgroundActivation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2
Vaughan, P. S., Aziz, F., van Wijnen, A. J., Wu, S., Harada, H., Taniguchi, T., Soprano, K. J., Stein, J. L., & Stein, G. S. (1995) · Nature · doi:10.1038/377362a0 · Cited by 189
Spi-1/PU.1 Transgenic Mice Develop Multistep Erythroleukemias
Moreau-Gachelin, F., Wendling, F., Molina, T., Denis, N., Titeux, M., Grimber, G., Briand, P., Vainchenker, W., & Tavitian, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2453 · Cited by 189
Wang, I.-M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., & Ozato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.271 · Cited by 187
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452 · Cited by 182
c-Jun Is a JNK-independent Coactivator of the PU.1 Transcription Factor
Behre, G., Whitmarsh, A. J., Coghlan, M. P., Hoang, T., Carpenter, C. L., Zhang, D.-E., Davis, R. J., & Tenen, D. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.4939 · Cited by 180
Eklund, E. A., Jalava, A., & Kakar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13957 · Cited by 176
Bovolenta, C., Driggers, P. H., Marks, M. S., Medin, J. A., Politis, A. D., Vogel, S. N., Levy, D. E., Sakaguchi, K., Appella, E., & Coligan, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5046 · Cited by 167
Jesse, T. L., LaChance, R., Iademarco, M. F., & Dean, D. C. (1998) · Journal of Cell Biology · doi:10.1083/jcb.140.5.1265 · Cited by 167
Induction of IFN-γ in macrophages by lipopolysaccharide
Fultz, M. J., Barber, S. A., Dieffenbach, C. W., & Vogel, S. N. (1993) · International Immunology · doi:10.1093/intimm/5.11.1383 · Cited by 165
Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162
Giese, N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., & Morse, H. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1535 · Cited by 160
Fisher, R. C., & Scott, E. W. (1998) · STEM CELLS · doi:10.1002/stem.160025 · Cited by 158
Weisz, A., Marx, P., Sharf, R., Appella, E., Driggers, P. H., Ozato, K., & Levi, B. Z. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74081-2 · Cited by 152
The transcription factor PU.1 is involved in macrophage proliferation.
Celada, A., Borràs, F. E., Soler, C., Lloberas, J., Klemsz, M., van Beveren, C., McKercher, S., & Maki, R. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.61 · Cited by 152 · cited 4×
“In some instances, binding of both factors to DNA is required; in others, PU.1 may actually tether another factor to the DNA, as has been reported for c-Jun on the M-CSF promoter and C/EBPβ on the IL-1β promoter (35,36).”
BackgroundInfluentialWestermarck, J. K., Seth, A. K., & Kähäri, V. (1997) · Oncogene · doi:10.1038/sj.onc.1201111 · Cited by 149
Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147
Kominato, Y., Galson, D. L., Waterman, W. R., Webb, A. C., & Auron, P. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.59 · Cited by 146
ETS1, NFκB and AP1 synergistically transactivate the human GM – CSF promoter
Thomas, R. S., Tymms, M. J., McKinlay, L. H., Shannon, M. F., Seth, A. K., & Kola, I. (1997) · Oncogene · doi:10.1038/sj.onc.1201125 · Cited by 145
Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143
Bassuk, A. G., Anandappa, R. T., & Leiden, J. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3563-3573.1997 · Cited by 136
Gobin, S. J. P., van Zutphen, M., Woltman, A. M., & van den Elsen, P. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1428 · Cited by 136
Takaoka, A., Tanaka, N., Mitani, Y., Miyazaki, T., Fujii, H., Sato, M., Kovarik, P., Decker, T., Schlessinger, J., & Taniguchi, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2480 · Cited by 133
Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burýšek, L., Yeow, W.-S., & Pitha, P. M. (1999) · PubMed · Cited by 127
Masumi, A., Wang, I.-M., Lefebvre, B., Yang, X.-J., Nakatani, Y., & Ozato, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1810 · Cited by 124
Lau, J. F., Parisien, J.-P., & Horvath, C. M. (2000) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.97.13.7278 · Cited by 120
IL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119
The Ets protein Spi-B is expressed exclusively in B cells and T cells during development.
Su, G. H., Ip, H. S., Cobb, B. S., Lu, M. M., Chen, H. M., & Simon, M. C. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.1.203 · Cited by 113
Physical and functional interactions between the transcription factor PU.1 and the coactivator CBP
Yamamoto, H., Kihara-Negishi, F., Yamada, T., Hashimoto, Y., & Oikawa, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202427 · Cited by 113 · cited 3×
“1 has been reported to interact with the histone acetylase CREB binding protein (CBP) (16), implicating PU.”
BackgroundInfluentialNagulapalli, S., Pongubala, J. M., & Atchison, M. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4330 · Cited by 110
Spi-1/PU.1: an oncogene of the Ets family
Moreau-Gachelin, F. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90011-6 · Cited by 110
Lodie, T. A., Savedra, R., Golenbock, D. T., Van Beveren, C. P., Maki, R. A., & Fenton, M. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1848 · Cited by 106
Self-citationRoles of IFN Consensus Sequence Binding Protein and PU.1 in Regulating IL-18 Gene Expression
Kim, Y.-M., Kang, H.-S., Paik, S., Pyun, K.-H., Anderson, K. L., Torbett, B. E., & Choi, I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.2000 · Cited by 103
Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R., & Levi, B.-Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13063 · Cited by 100
Suzuki, S., Kumatori, A., Haagen, I.-A., Fujii, Y., Sadat, M., Jun, H. L., Tsuji, Y., Roos, D., & Nakamura, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6085 · Cited by 99
Szymczyna, B. R., & Arrowsmith, C. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004294200 · Cited by 99
NF-IL6 (C/EBPβ) Vigorously Activates il1b Gene Expression via a Spi-1 (PU.1) Protein-Protein Tether
Yang, Z., Wara-aswapati, N., Chen, C., Tsukada, J., & Auron, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000145200 · Cited by 92
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
Self-citationPU.1 can participate in an active enhancer complex without its transcriptional activation domain
Pongubala, J. M. R., & Atchison, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.127 · Cited by 86
Moulton, K. S., Semple, K., Wu, H., & Glass, C. K. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4408 · Cited by 86
Yabu, T., Hirose, H., Hırono, I., Katagiri, T., Aoki, T., & Yamamoto, E. (1998) · PubMed · Cited by 83
Pio, F., Kodandapani, R., Ni, C.-Z., Shepard, W., Klemsz, M., McKercher, S. R., Maki, R. A., & Ely, K. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23329 · Cited by 81
A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity
Lin, R., Lin, R., Hiscott, J. B., Hiscott, J. B., & Hiscott, J. B. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006850009017 · Cited by 77
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77
Tsukada, J., Waterman, W. R., Koyama, Y., Webb, A. C., & Auron, P. E. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2183 · Cited by 77
Contursi, C., Wang, I.-M., Gabriele, L., Gadina, M., O'Shea, J., Morse, H. C., & Ozato, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.91 · Cited by 72
Politis, A. D., Sivo, J., Driggers, P. H., Ozato, K., & Vogel, S. N. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.3.801 · Cited by 68 · cited 1×
“IRF-4 expression does not appear to be modulated by IFN-γ stimulation, whereas ICSBP expression is strongly induced (53,77).”
BackgroundHimmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 68
Interferon Regulatory Factor-2 Directs Transcription from the gp91 Promoter
Luo, W., & Skalnik, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23445 · Cited by 67
Regulation of IFN Consensus Sequence Binding Protein Expression in Murine Macrophages
Kantakamalakul, W., Politis, A. D., Marecki, S., Sullivan, T., Ozato, K., Fenton, M. J., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7417 · Cited by 61
Self-citationPolitis, A. D., Ozato, K., Coligan, J. E., & Vogel, S. N. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.5.2270 · Cited by 61
Grossman, A., Mittrücker, H.-W., Nicholl, J., Suzuki, A., Chung, S., Antonio, L., Suggs, S., Sutherland, G. R., Siderovski, D. P., & Mak, T. W. (1996) · Genomics · doi:10.1006/geno.1996.0547 · Cited by 60
The [(G/C)3NN]n motif: a common DNA repeat that excludes nucleosomes.
Wang, Y. H., & Griffith, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8863 · Cited by 56
Commitment to the Monocytic Lineage Occurs in the Absence of the Transcription Factor PU.1
Henkel, G. W., McKercher, S. R., Leenen, P. J. M., & Maki, R. A. (1999) · Blood · doi:10.1182/blood.v93.9.2849 · Cited by 53
Spi-C, a Novel Ets Protein That Is Temporally Regulated during B Lymphocyte Development
Bemark, M., Mårtensson, A., Liberg, D., & Leanderson, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10259 · Cited by 52
ETS Protein–Dependent Accessibility Changes at the Immunoglobulin μ Heavy Chain Enhancer
Nikolajczyk, B. S., Sanchez, J. A., & Sen, R. (1999) · Immunity · doi:10.1016/s1074-7613(00)80077-1 · Cited by 51
IFN consenus sequence binding protein (ICSBP) is a conditional repressor of IFN inducible promoters
Welsz, A., Kirchhoff, S., & Levi, B.-Z. (1994) · International Immunology · doi:10.1093/intimm/6.8.1125 · Cited by 50 · cited 1×
“Some of these genes include MHC-I (H-2Ld), 2′-5′-oligo-adenylate synthetase (OAS) and interferon-stimulated gene 54 (ISG54) (74,79,80).”
BackgroundFisher, R. C., Olson, M. C., Pongubala, J. M. R., Perkel, J. M., Atchison, M. L., Scott, E. W., & Simon, M. C. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4347 · Cited by 49
Rao, S., Matsumura, A., Yoon, J. W., & Simon, M. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11115 · Cited by 46
Ortiz, M. A., Light, J. P., Maki, R. A., & Assa‐Munt, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2740 · Cited by 44
DNA Methylation and Chromatin Structure Regulate PU.1 Expression
Amaravadi, L., & Klemsz, M. J. (1999) · DNA and Cell Biology · doi:10.1089/104454999314737 · Cited by 44
Cheng, G., NAZAR, A. S. M. I., Shin, H. S., Vanguri, P., & Shin, M. L. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.987 · Cited by 43
Repression of I-Aβ Gene Expression by the Transcription Factor PU.1
Borràs, F. E., Lloberas, J., Maki, R. A., & Celada, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24385 · Cited by 40
Lodie, T. A., Reiner, M., Coniglio, S. J., Viglianti, G. A., & Fenton, M. J. (1998) · PubMed · Cited by 39
Self-citationBuras, J. A., Monks, B. G., & Fenton, M. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4444 · Cited by 39
Self-citationCooperative interaction between the DNA-binding domains of PU.1 and IRF4
Yee, A. A., Yin, P., Siderovski, D. P., Mak, T. W., Litchfield, D. W., & Arrowsmith, C. H. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1838 · Cited by 38
López‐Rodríguez, C., & Corbí, A. L. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270804 · Cited by 36
Role of Asymmetric Phosphate Neutralization in DNA Bending by PU.1
Strauss-Soukup, J. K., & Maher, L. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31570 · Cited by 31
PU.1 and USF Are Required for Macrophage-specific Mannose Receptor Promoter Activity
Egan, B. S., Lane, K. B., & Shepherd, V. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9098 · Cited by 30
Li, W., Nagineni, C. N., Ge, H., Efiok, B. J. S., Chepelinsky, A. B., & Egwuagu, C. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9686 · Cited by 28
Li, W., Nagineni, C. N., Hooks, J. J., Chepelinsky, A. B., & Egwuagu, C. E. (1999) · PubMed · Cited by 25
Furui, J., Uegaki, K., Yamazaki, T., Shirakawa, M., Swindells, M. B., Harada, H., Taniguchi, T., & Kyogoku, Y. (1998) · Structure · doi:10.1016/s0969-2126(98)00050-1 · Cited by 25
Inaba, T., Gotoda, T., Ishibashi, S., Harada, K., Ohsuga, J.-I., Ohashi, K., Yazaki, Y., & Yamada, N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2264 · Cited by 24
Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulation
Nguyen, H., Teskey, L., Lin, R., & Hiscott, J. B. (1999) · Oncogene · doi:10.1038/sj.onc.1202924 · Cited by 24
Buras, J. A., Reenstra, W. R., & Fenton, M. J. (1995) · Molecular Immunology · doi:10.1016/0161-5890(95)00018-a · Cited by 23
Self-citationGross, P., Yee, A. A., Arrowsmith, C. H., & Macgregor, R. B. (1998) · Biochemistry · doi:10.1021/bi9731448 · Cited by 23
Gupta, S. K., Xia, D., Jiang, M., Lee, S.-J., & Pernis, A. B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.5997 · Cited by 23
In vivo formation of IRF-1 homodimers
Kirchhoff, S., Schaper, F., Oumard, A., & Häuser, H. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80019-4 · Cited by 20
Flagged first, then by citations
Cited by
Sorted by citations
Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma
Yang, Y., Shaffer, A. L., Emre, N. C. T., Ceribelli, M., Zhang, M., Wright, G. W., Xiao, W., Powell, J. I., Platig, J., Kohlhammer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.024 · Cited by 540
Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis
Zhao, B., Takami, M., Yamada, A., Wang, X., Koga, T., Hu, X., Tamura, T., Ozato, K., Choi, Y., Ivashkiv, L. B., et al. (2009) · Nature Medicine · doi:10.1038/nm.2007 · Cited by 316
Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis
Dakic, A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., & Nutt, S. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050075 · Cited by 297
Toll-Like Receptor Signaling and Regulation of Cytokine Gene Expression in the Immune System
Ozato, K., Tsujimura, H., & Tamura, T. (2002) · BioTechniques · doi:10.2144/oct0208 · Cited by 189
Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells
Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 162
Nehyba, J., Hrdličková, R., & Bose, H. R. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp167 · Cited by 153
When Ets transcription factors meet their partners
Verger, A., & Duterque‐Coquillaud, M. (2002) · BioEssays · doi:10.1002/bies.10068 · Cited by 134
Monocyte differentiation and macrophage polarization
Orekhov, A. N., Orekhova, V. A., Nikiforov, N. G., Myasoedova, V. A., Grechko, A. V., Romanenko, E. B., Zhang, D., & Chistiakov, D. A. (2019) · Vessel Plus · doi:10.20517/2574-1209.2019.04 · Cited by 144
Kuo, T. C., & Calame, K. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5556 · Cited by 132
Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU. 1 complex
Kanno, Y., Levi, B.-Z., Tamura, T., & Ozato, K. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.770 · Cited by 128
Barnes, B. J., Field, A. E., & Pitha-Rowe, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212609200 · Cited by 119
Hosokawa, H., Ungerbäck, J., Wang, X., Matsumoto, M., Nakayama, K. I., Cohen, S. M., Tanaka, T., & Rothenberg, E. V. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.024 · Cited by 116
Lehtonen, A., Veckman, V., Nikula, T., Lahesmaa, R., Kinnunen, L., Matikainen, S., & Julkunen, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6570 · Cited by 120
Marecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111
Self-citationMeraro, D., Gleit-Kielmanowicz, M., Hauser, H., & Levi, B.-Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6224 · Cited by 105
Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development
Rothenberg, E. V., Hosokawa, H., & Ungerbäck, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00228 · Cited by 99
Transcription factor PU.1 and immune cell differentiation (Review)
Li, G., Hao, W., & Hu, W. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4763 · Cited by 98
Regulation of human β2-microglobulin transactivation in hematopoietic cells
Gobin, S. J. P., Biesta, P. J., & van den Elsen, P. J. (2003) · Blood · doi:10.1182/blood-2002-09-2924 · Cited by 86
TREM‐1 expression in macrophages is regulated at transcriptional level by NF‐κB and PU.1
Zeng, H., Ornatowska, M., Joo, M., & Sadikot, R. T. (2007) · European Journal of Immunology · doi:10.1002/eji.200737270 · Cited by 88
Identification of IRF-8 and IRF-1 target genes in activated macrophages
Dror, N., Alter-Koltunoff, M., Azriel, A., Amariglio, N., Jacob‐Hirsch, J., Zeligson, S., Morgenstern, A., Tamura, T., Häuser, H., Rechavi, G., et al. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.02.026 · Cited by 79
Gupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
Dakic, A., Wu, L., & Nutt, S. L. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.006 · Cited by 72
Review: ICSBP/IRF-8 Transactivation: A Tale of Protein-Protein Interaction
Levi, B.-Z., Hashmueli, S., Gleit-Kielmanowicz, M., Azriel, A., & Meraro, D. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452764 · Cited by 70
Chen, G.-B., Tan, C., Teh, B. K., & Lu, J.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286427 · Cited by 70
Smith, M. A., Wright, G. M., Wu, J., Tailor, P. B., Ozato, K., Chen, X., Wei, S., Piskurich, J. F., Ting, J. P. ‐., & Wright, K. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165431 · Cited by 63
Sharma, S., Grandvaux, N., Mamane, Y., Génin, P., Azimi, N., Waldmann, T. A., & Hiscott, J. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3120 · Cited by 61
van der Stoep, N., Quinten, E., Rezende, M. M., & van den Elsen, P. J. (2004) · Blood · doi:10.1182/blood-2004-03-0790 · Cited by 58
Shin, D., Lee, C., & Morse, H. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027384 · Cited by 59
Schmidt, M., Bies, J., Tamura, T., Ozato, K., & Wolff, L. (2004) · Blood · doi:10.1182/blood-2003-01-0285 · Cited by 58
PU.1 and ICSBP control constitutive and IFN-γ-regulatedTlr9gene expression in mouse macrophages
Schroder, K., Lichtinger, M., Irvine, K. M., Brion, K., Trieu, A., Ross, I. L., Ravasi, T., Stacey, K. J., Rehli, M., Hume, D. A., et al. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0107036 · Cited by 51
Ieki, K., Matsukura, S., Kokubu, F., Kimura, T., Kuga, H., Kawaguchi, M., Odaka, M., Suzuki, S., Watanabe, S., Takeuchi, H. T., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.1941.x · Cited by 48
Laricchia‐Robbio, L., Tamura, T., Karpova, T., Sprague, B. L., McNally, J. G., & Ozato, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504014102 · Cited by 48
Transcriptional Regulation of Mouse μ Opioid Receptor Gene by PU.1
Hwang, C. K., Kim, C. S., Choi, H. S., McKercher, S. R., & Loh, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400755200 · Cited by 46
Rhodes, J. D., Lott, M. C., Russell, S., Moulton, V., Sanderson, J., Wormstone, I. M., & Broadway, D. C. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr515 · Cited by 47
Origins of lymphocyte developmental programs: transcription factor evidence
Rothenberg, E. V., & Pant, R. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.08.002 · Cited by 42
Alter-Koltunoff, M., Ehrlich, S., Dror, N., Azriel, A., Eilers, M., Häuser, H., Bowen, H., Barton, C. H., Tamura, T., Ozato, K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307954200 · Cited by 42
Specificity and Function of IRF Family Transcription Factors: Insights from Genomics
Mancino, A., & Natoli, G. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0004 · Cited by 39
Maggi, L. B., Moran, J. M., Buller, R. M. L., & Corbett, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211744200 · Cited by 40
Karrich, J. J., Balzarolo, M., Schmidlin, H., Libouban, M. A. A., Nagasawa, M., Gentek, R., Kamihira, S., Maeda, T., Amsen, D., Wolkers, M. C., et al. (2012) · Blood · doi:10.1182/blood-2011-07-370239 · Cited by 42
Repression of IRF-4 target genes in human T cell leukemia virus-1 infection
Mamane, Y., Grandvaux, N., Hernandez, E., Sharma, S., Innocente, S. A., Lee, J. M., Azimi, N., Lin, R., & Hiscott, J. B. (2002) · Oncogene · doi:10.1038/sj.onc.1205843 · Cited by 35
Dekoninck, A., Calomme, C., Nizet, S., de Launoit, Y., Burny, A., Ghysdael, J., & Lint, C. M. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206392 · Cited by 35
The Roles of Monocytes and Macrophages in Behçet’s Disease With Focus on M1 and M2 Polarization
Hirahara, L., Takase‐Minegishi, K., Kirino, Y., Iizuka-Iribe, Y., Soejima, Y., Yoshimi, R., & Nakajima, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.852297 · Cited by 32
Mazzi, P., Donini, M., Margotto, D., Wientjes, F., & Dusi, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4941 · Cited by 30
Yashiro, T., Yamamoto, M., Araumi, S., Hara, M., Yogo, K., Uchida, K., Kasakura, K., & Nishiyama, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649572 · Cited by 31
PU.1 Binds to a Distal Regulatory Element That Is Necessary for B Cell-Specific Expression of CIITA
Yoon, H., & Boss, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000079 · Cited by 29
Review: IRF-4 Activities in HTLV-I-Induced T Cell Leukemogenesis
Mamane, Y., Sharma, S., Grandvaux, N., Hernandez, E., & Hiscott, J. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452746 · Cited by 28
Interferon regulatory factor 8 governs myeloid cell development
Xia, X., Wang, W., Yin, K., & Wang, S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.03.003 · Cited by 23
Nrf2 regulates PU.1 expression and activity in the alveolar macrophage
Staitieh, B. S., Fan, X., Neveu, W. A., & Guidot, D. M. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00355.2014 · Cited by 22
PU.1 Regulates Cathepsin S Expression in Large Yellow Croaker (Larimichthys crocea) Macrophages
Zhang, X.-Y., Zhuo, X., Cheng, J., Wang, X., Liang, K., & Chen, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.819029 · Cited by 21
PU.1 Regulates Cathepsin S Expression in Professional APCs
Wang, Y., Baron, R. M., Zhu, G., Joo, M., Christman, J. W., Silverman, E. S., Perrella, M. A., Riese, R. J., & Cernadas, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.275 · Cited by 21
Yashiro, T., Takeuchi, H., Nakamura, S., Tanabe, A., Hara, M., Uchida, K., Okumura, K., Kasakura, K., & Nishiyama, C. (2019) · The FASEB Journal · doi:10.1096/fj.201900379rr · Cited by 20
Mononuclear phagocyte regulation by the transcription factor Blimp‐1 in health and disease
Ulmert, I., Henriques‐Oliveira, L., Pereira, C., & Lahl, K. (2020) · Immunology · doi:10.1111/imm.13249 · Cited by 18
Borghini, L., Lu, J., Hibberd, M. L., & Dávila, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800246 · Cited by 19
Building promoter aware transcriptional regulatory networks using siRNA perturbation and deepCAGE
Vitezic, M., Lassmann, T., Forrest, A. R. R., Suzuki, M., Tomaru, Y., Kawai, J., Carninci, P., Suzuki, H., Hayashizaki, Y., & Daub, C. O. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq729 · Cited by 15
The Prolyl Isomerase Pin1 Modulates Development of CD8+ cDC in Mice
Barberi, T. J., Dunkle, A. D., He, Y.-W., Racioppi, L., & Means, A. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029808 · Cited by 14
Marden, C. M., Stefanidis, D., Cunninghame‐Graham, D. S., & Casimir, C. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00727-7 · Cited by 13
PML is a key component for the differentiation of myeloid progenitor cells to macrophages
Khalfin-Rabinovich, Y., Weinstein, A., & Levi, B.-Z. (2011) · International Immunology · doi:10.1093/intimm/dxr004 · Cited by 12
Nakano, N., Nishiyama, C., Masuoka, N., Nishiyama, M., Yamane, H., Okumura, K., & Ogawa, H. (2005) · Immunogenetics · doi:10.1007/s00251-004-0754-2 · Cited by 11
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
“Moreover, PU.1 appeared twice in the list – asboth a member of the ETS family and as a co-factor in the ETS/IRF (interferon regulatory factor)family oftranscriptionfactors, arelationship thatiswell documented 30 (Fig.2A).”
Hashmueli, S. (2003) · International Immunology · doi:10.1093/intimm/dxg077 · Cited by 9
Chen, K. Y., Angulo, A. D., Guo, X., More, A., Ochsner, S. A., Lopez, E., Saul, D., Pang, W., Sun, Y., McKenna, N. J., et al. (2022) · Frontiers in Aging · doi:10.3389/fragi.2021.803482 · Cited by 8
Liu, S., & Wang, Z. (2022) · Disease Markers · doi:10.1155/2022/2561673 · Cited by 8
PU.1 directly regulates retinoic acid-induced expression of RIG-G in leukemia cells
Gu, Z.-M., Liu, C., Wu, S.-F., Zhao, M. L., Xu, H.-Z., Liu, W., Zhou, H.-C., Chen, G., & Wu, Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.021 · Cited by 7
KDM6A Lysine Demethylase Directs Epigenetic Polarity of MDSCs during Murine Sepsis
Bah, I., Alkhateeb, T., Youssef, D. A., Yao, Z. Q., McCall, C. E., & Gazzar, M. E. (2021) · Journal of Innate Immunity · doi:10.1159/000517407 · Cited by 5
Regulatory Co-options in the Evolution of Deuterostome Immune Systems
Rothenberg, E., & Davidson, E. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-320-0_4 · Cited by 2
Shimokawa, N., Nishiyama, C., Nakano, N., Maeda, K., Suzuki, R., Hara, M., Fukai, T., Tokura, T., Miyajima, H., Nakao, A., et al. (2010) · Immunogenetics · doi:10.1007/s00251-010-0444-1 · Cited by 5
Overexpression of IRF8 and Pu.1 in B cells of systemic lupus erythematosus patients
Azizan, A., Farhadi, E., Faezi, S. T., Alikhani, M., Jamshidi, A., Vodjgani, M., & Mahmoudi, M. (2025) · Lupus · doi:10.1177/09612033251366400 · Cited by 1
Inferring transcriptional regulation on the promoter level and its applications to diseases
Vitezic, M. (2013) · Figshare
Transcription Factors: Deciphering the Transcription Factor Network of Dendritic Cell Development
Hieronymus, T., & Zenke, M. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch4
Expression and activation of STAT and IRF family transcription factors in mononuclear leukocytes
Lehtonen, A. (2005) · Työväentutkimus Vuosikirja
Roles for Pin1 in Modulating Cells of the Innate Immune System
Barberi, T. J. (2011) · DukeSpace (Duke University)
The Transcriptional Regulation of HLA-E by Interferon-Gamma in Tumor Cells
Grant, Q. (2010) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/9hab-qt04
Metadata
- Authors
- Marecki, S., & Fenton, M. J.
- Affiliations
- Boston University (US)
- ORCID
- Fenton, Matthew J.
- Venue
- Cell Biochemistry and Biophysics
- Published
- 2000
- Volume
- 33
- Issue
- 2
- Pages
- 127-148
- ISSN
- 1085-9195 (ISSN-L)
- OpenAlex
- W2330690422
- Semantic Scholar
- 1f32d4a50efbfa831a0783908370cea0e52d57cd
- Cited by
- 74
- References
- 117
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 1 · 2016: 1 · 2015: 1 · 2013: 1 · 2012: 3
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell Biochemistry and Biophysics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- PU.1, interferon regulatory factors, IRF8, IRF4, ETS transcription factors, transcriptional regulation, protein-protein interaction, phosphorylation, DNA-binding motifs, innate immunity, transcription factor complex
- MeSH terms
- Interferon Regulatory Factor-8, Interferon Regulatory Factor-4, Proto-Oncogene Protein Spi-1, Animals, Binding Sites, DNA, DNA-Binding Proteins, Gene Expression Regulation, Humans, Interferons, Proto-Oncogene Proteins, Repetitive Sequences, Nucleic Acid, Repressor Proteins, Transcription Factors, Transcription, Genetic, Trans-Activators, Consensus Sequence, Proto-Oncogene Proteins c-ets, Interferon Regulatory Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review